These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 16022568

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CCR1 antagonists for the treatment of autoimmune diseases.
    Gladue RP, Zwillich SH, Clucas AT, Brown MF.
    Curr Opin Investig Drugs; 2004 May; 5(5):499-504. PubMed ID: 15202722
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases.
    Gladue RP, Tylaska LA, Brissette WH, Lira PD, Kath JC, Poss CS, Brown MF, Paradis TJ, Conklyn MJ, Ogborne KT, McGlynn MA, Lillie BM, DiRico AP, Mairs EN, McElroy EB, Martin WH, Stock IA, Shepard RM, Showell HJ, Neote K.
    J Biol Chem; 2003 Oct 17; 278(42):40473-80. PubMed ID: 12909630
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of chemokines and chemokine receptors during human renal transplant rejection.
    Segerer S, Cui Y, Eitner F, Goodpaster T, Hudkins KL, Mack M, Cartron JP, Colin Y, Schlondorff D, Alpers CE.
    Am J Kidney Dis; 2001 Mar 17; 37(3):518-31. PubMed ID: 11228176
    [Abstract] [Full Text] [Related]

  • 7. Chemokine and chemokine receptor blockade in arthritis, a prototype of immune-mediated inflammatory diseases.
    Szekanecz Z, Koch AE, Tak PP.
    Neth J Med; 2011 Sep 17; 69(9):356-66. PubMed ID: 21978977
    [Abstract] [Full Text] [Related]

  • 8. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
    Tian Y, New DC, Yung LY, Allen RA, Slocombe PM, Twomey BM, Lee MMK, Wong YH.
    Eur J Immunol; 2004 Mar 17; 34(3):785-795. PubMed ID: 14991608
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338.
    Carter PH, Hynes J.
    Expert Opin Ther Pat; 2010 Nov 17; 20(11):1609-18. PubMed ID: 20858032
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Discovery of novel non-peptide CCR1 receptor antagonists.
    Ng HP, May K, Bauman JG, Ghannam A, Islam I, Liang M, Horuk R, Hesselgesser J, Snider RM, Perez HD, Morrissey MM.
    J Med Chem; 1999 Nov 04; 42(22):4680-94. PubMed ID: 10579830
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blockade of chemokine signaling in patients with multiple sclerosis.
    Zipp F, Hartung HP, Hillert J, Schimrigk S, Trebst C, Stangel M, Infante-Duarte C, Jakobs P, Wolf C, Sandbrink R, Pohl C, Filippi M, CCR1 Antagonist Study Group.
    Neurology; 2006 Nov 28; 67(10):1880-3. PubMed ID: 17130431
    [Abstract] [Full Text] [Related]

  • 20. [Chemokine--possible new options for the treatment of multiple sclerosis].
    Trebst C, Ransohoff RM, Windhagen A, Stangel M.
    Nervenarzt; 2003 Oct 28; 74(10):850-7. PubMed ID: 14551688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.